Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
60 hedge funds and large institutions have $94.5M invested in Ampio Pharmaceuticals Inc. in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 1 closing their positions.
1,500% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 1
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
175% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 8
154% more capital invested
Capital invested by funds: $37.2M → $94.5M (+$57.2M)
79% more call options, than puts
Call options by funds: $1.9M | Put options by funds: $1.06M
33% more funds holding
Funds holding: 45 → 60 (+15)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$8.55M |
| 2 |
TC
Talkot Capital
Sausalito,
California
|
+$8.27M |
| 3 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$4.63M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.74M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.1M |
| 2 |
TCIM
TIAA CREF Investment Management
New York
|
-$89K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$67.6K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$23.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$13.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $38K | +$32.9K | +17 | New |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $33K | +$29K | +15 | New |
|
53
Ameriprise
Minneapolis,
Minnesota
| $13K | – | – | – |
|
|
TWA
54
TCI Wealth Advisors
Tucson,
Arizona
| $11K | – | – | – |
|
|
EWM
55
Evercore Wealth Management
New York
| $8K | +$5.8K | +3 | New |
|
56
Barclays
London,
United Kingdom
| $7K | -$3.87K | -2 | -40% |
|
57
BlackRock
New York
| $7K | – | – | – |
|
|
58
Bank of America
Charlotte,
North Carolina
| $3K | -$13.5K | -7 | -88% |
|
|
RFC
59
Russell Frank Company
Seattle,
Washington
| $2K | – | – | – |
|
60
Citigroup
New York
| $1K | – | – | – |
|
|
61
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $193 | -$23.2K | -12 | -12% |
|
|
62
BNP Paribas Financial Markets
Paris,
France
| – | -$67.6K | -39 | Closed |
|
AMPE Hedge Fund Activity: Q3 2013 in Review
60 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2013, worth a combined $94.5M — up 154% from $37.2M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new AMPE positions and 1 closed out — a net gain of 15 holders — while 22 added to existing stakes and 8 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $8.55M. The largest seller was BlackRock Institutional Trust, cutting an estimated $1.1M.
- 60 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2013, up from 45 in Q2 2013.
- Funds reported $94.5M of Ampio Pharmaceuticals Inc. stock for Q3 2013, up 154% quarter-over-quarter.
- 16 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2013 and 1 closed out, a net change of +15 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2013 was RA Capital Management, an estimated $8.55M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2013 was BlackRock Institutional Trust, an estimated $1.1M sold.
Based on aggregated 13F filings for Q3 2013.